research Multiple Sclerosis Disease-Modifying Therapies: Adverse Effect Surveillance and Management
The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.
Search
for
Sort by
Research
540-570 / 1000+ results 
research Nail Loss After Teriflunomide Treatment: A New Potential Adverse Event
Nail loss may be a side effect of the MS drug teriflunomide.
research Teriflunomide and Hair Disorders
Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.
research Prevalence of Polycystic Ovary Syndrome in Women in China: A Large Community-Based Study
PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.
research Disease Modifying Agent Related Skin Reactions in Multiple Sclerosis: Prevention, Assessment, and Management
The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.
research Androgenetic Alopecia, Metabolic Syndrome, and Insulin Resistance: Is There Any Association? A Case-Control Study
Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.
research Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case-Control Study
People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.
research Prevalence of Metabolic Syndrome in the Family Members of Women with Polycystic Ovary Syndrome from North India
Family members of North Indian women with PCOS have a high rate of metabolic syndrome.
research The Association of Insulin Resistance and Metabolic Syndrome in Early Androgenetic Alopecia
People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.
research Is There Really a Relationship Between Androgenetic Alopecia and Metabolic Syndrome?
No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.
research Hair Growth Promoting Effect of Bioactive Extract from Deer Antler Velvet-Loaded Niosomes and Microspicules Serum
Deer antler velvet serum helps hair grow and is safe for skin.
research Metabolic Syndrome and Insulin Resistance Syndrome Among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam
Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.
research Isotope Dilution-Based Targeted and Nontargeted Carbonyl Neurosteroid/Steroid Profiling
Researchers created a new method to measure brain steroids, finding higher levels of certain steroids and changes due to a drug.
research The Association of Metabolic Syndrome and Insulin Resistance in Early-Onset Androgenetic Alopecia in Males: A Case-Control Study
Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.
research Comparing Classic and Newer Phenotypes in Greek PCOS Women: The Prevalence of Metabolic Syndrome and Their Association with Insulin Resistance
Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.
research Association Between Androgenetic Alopecia and Metabolic Syndrome: A Meta-Analysis
People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.
research Inhibition of Class I HDACs Preserves Hair Follicle Inductivity in Postnatal Dermal Cells
Inhibiting class I HDACs helps maintain hair growth ability in skin cells.
research Elicitor Mediated Enhancement of Wedelolactone in Cell Suspension Culture of Eclipta Alba (L.) Hassk
Adding yeast extract and methyl jasmonate to Eclipta alba cell cultures increased the production of the compound wedelolactone.
research The Association of Cutaneous Lichen Planus and Metabolic Syndrome: A Case-Control Study
People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.
research Female Pattern Hair Loss and Metabolic Syndrome in Premenopausal Women
Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.
research Synthesis of N-Substituted 3-Oxo-17b-Carboxamide-4-Aza-5a-Androstanes and the Tautomerism of 3-Oxo-4-Aza-5-Androstenes
Researchers made two new compounds that could be used for medicine.
research 3D Multicellular Micropatterning Biomaterials for Hair Regeneration and Vascularization
The new biomaterial helps grow blood vessels and hair for skin repair.
research Medical Comorbidities and the Onset of Androgenetic Alopecia: A Population-Based, Case-Control Study
Early hair loss may be linked to metabolic syndrome.
research YKL-40: A Sensitive Biomarker for Early Androgenetic Alopecia and Early Hidden Metabolic Syndrome
High YKL-40 levels predict early hair loss and hidden metabolic issues.
research Severe Androgenetic Alopecia as a Marker of Metabolic Syndrome in Male Patients: A Hospital-Based Case Control Study
Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.
research A Study of the Prevalence of Metabolic Syndrome in Premenopausal Women With Female Pattern Hair Loss: A Case-Control Study
Women with female pattern hair loss may have a higher risk of metabolic syndrome.
research Microsponges-Mediated Targeted Topical Delivery of Rosemary Oil for Hair Growth Promotion: Optimization and In-Vivo Studies
Microsponges with rosemary oil significantly improve hair growth compared to regular rosemary oil and minoxidil.
research Efficacy of Clinical and Pathogenetic Treatment of Patients with Alopecia Areata Associated with Metabolic Syndrome
The study evaluated a complex treatment method for alopecia areata (AA) associated with metabolic syndrome (MS) in 59 patients, focusing on correcting dyslipidaemia and insulin resistance. Patients were divided into four groups, receiving various combinations of basic therapy, rosuvastatin, thioctacid, and dietary adjustments. Results showed that group 1C, which received both rosuvastatin and thioctacid, had the most significant improvements in metabolic indicators and the highest rates of clinical recovery after 6 and 12 months. The study concluded that the pathogenetically substantiated treatment method effectively improved outcomes for patients with AA and MS.
research Multiple Sclerosis and Alopecia Areata: Drug-Induced Alopecia Areata or Coexisting Autoimmune Phenomena?
Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.
research The Importance of Biomedical Engineers in the Health System
Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.